Your session is about to expire
← Back to Search
Other
A Sub-Chronic Evaluation of the Safety of Celastrol in Human Subjects
N/A
Waitlist Available
Led By Rubin Patel, MD
Research Sponsored by Legend Labz, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the safety of Celastrol, a natural compound from a plant, in healthy adults aged 18-40. Celastrol may help reduce inflammation and protect cells from damage. The study will monitor participants for three months to ensure it is safe to use. Celastrol is a natural compound derived from the roots of Tripterygium wilfordii, traditionally used in Chinese medicine for its anti-inflammatory and antioxidant properties.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Liver
Secondary study objectives
ALT (U/L)
SGOT - Glutamate oxaloacetate transaminase
Absolute Basophils (K/UL)
+39 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Amount of Celastrol AdministeredExperimental Treatment1 Intervention
Chronic evaluation of the same doses of Celastrol to each subject over 90-day period
Find a Location
Who is running the clinical trial?
Legend Labz, Inc.Lead Sponsor
1 Previous Clinical Trials
5 Total Patients Enrolled
Rubin Patel, MDPrincipal InvestigatorPatient Plus Urgent Care
1 Previous Clinical Trials
5 Total Patients Enrolled